At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ELAB Elevai Labs, Inc.
Post-Market Trading 05-03 18:48:19 EDT
0.7009
-0.0041
-0.58%
盘后0.6837
-0.0172-2.45%
18:30 EDT
High0.7185Low0.6300Vol530.62K
Open0.7100D1 Closing0.7050Amplitude12.55%
Mkt Cap12.15MTradable Cap4.05MTotal Shares17.33M
T/O358.08KT/O Rate9.19%Tradable Shares5.77M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
ELEVAI Labs Expands Portfolio and Restructures Subsidiaries
TIPRANKS  ·  05-03 05:42
ELEVAI Labs Expands Portfolio and Restructures Subsidiaries
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
GlobeNewswire  ·  05-02 20:30
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
GlobeNewswire  ·  05-01 20:00
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
GlobeNewswire  ·  05-01 13:00
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
GlobeNewswire  ·  04-29
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
GlobeNewswire  ·  04-22
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
Elevai Labs reports Q4 results
seekingalpha  ·  03-30
Elevai Labs reports Q4 results
Press Release: Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
Dow Jones  ·  03-30
Press Release: Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
15 Best Beauty Stocks To Invest In
Insider Monkey  ·  03-29
15 Best Beauty Stocks To Invest In
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
GlobeNewswire  ·  03-18
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
ELEVAI Labs Inc.: Stock Price Woes and Board Reshuffle
TIPRANKS  ·  03-08
ELEVAI Labs Inc.: Stock Price Woes and Board Reshuffle
ELEVAI LABS announces issuance of patent
seekingalpha  ·  01-24
ELEVAI LABS announces issuance of patent
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
GlobeNewswire  ·  01-24
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
NCAC, PTPI and CTSO among pre-market losers
seekingalpha  ·  01-18
NCAC, PTPI and CTSO among pre-market losers
ABAT, PRQR and SHOT among mid-day movers
seekingalpha  ·  01-18
ABAT, PRQR and SHOT among mid-day movers
ELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635M
seekingalpha  ·  01-17
ELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635M
ELAB, KIND and RLX among pre-market losers
seekingalpha  ·  01-17
ELAB, KIND and RLX among pre-market losers
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
GlobeNewswire  ·  01-17
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
Benzinga  ·  01-16
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
Elevai Labs, Allakos, TransCode Therapeutics among healthcare movers
seekingalpha  ·  01-16
Elevai Labs, Allakos, TransCode Therapeutics among healthcare movers

Introduction

Company Name.
Elevai Labs, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Issue price:
--